bioAffinity Technologies Plans $4 Million Cost Cut to Boost CyPath® Lung Sales

bioAffinity Technologies Plans $4 Million Cost Cut to Boost CyPath® Lung Sales bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive testing for early-stage lung cancer and other lung diseases, has outlined its latest strategic actions aimed…

Read MorebioAffinity Technologies Plans $4 Million Cost Cut to Boost CyPath® Lung Sales

Datavant Launches Upgraded Clinical Insights Platform for Payers and Providers

Datavant Launches Upgraded Clinical Insights Platform for Payers and Providers Datavant, a leader in health data platform solutions, has announced the launch of its enhanced Datavant Clinical Insights Platform, designed to transform how health plans and risk-bearing providers identify, access,…

Read MoreDatavant Launches Upgraded Clinical Insights Platform for Payers and Providers

Italfarmaco Updates on Givinostat for Duchenne Muscular Dystrophy: Access, Regulations, and Trials

Italfarmaco Updates on Givinostat for Duchenne Muscular Dystrophy: Access, Regulations, and Trials Italfarmaco S.p.A. has announced significant progress in the regulatory and clinical development of givinostat, its investigational drug for the treatment of Duchenne muscular dystrophy (DMD). The company provided…

Read MoreItalfarmaco Updates on Givinostat for Duchenne Muscular Dystrophy: Access, Regulations, and Trials

InterSystems Launches IntelliCare: AI-Powered Next-Gen EHR

InterSystems Launches IntelliCare: AI-Powered Next-Gen EHR InterSystems, a leading provider of innovative data technology managing over a billion health records globally, today unveiled InterSystems IntelliCare, a next-generation, AI-powered electronic health record (EHR) and healthcare information system. IntelliCare is designed to…

Read MoreInterSystems Launches IntelliCare: AI-Powered Next-Gen EHR

Philips Chooses AWS as Preferred Cloud Provider to Drive Innovation and Enhance Patient Outcomes

Philips Chooses AWS as Preferred Cloud Provider to Drive Innovation and Enhance Patient Outcomes Amazon Web Services, Inc. (AWS), part of Amazon.com, Inc. (NASDAQ: AMZN), has announced that Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology,…

Read MorePhilips Chooses AWS as Preferred Cloud Provider to Drive Innovation and Enhance Patient Outcomes

ENCell’s EN001 Gets FDA Orphan Drug Status for Charcot-Marie-Tooth Disease

ENCell’s EN001 Gets FDA Orphan Drug Status for Charcot-Marie-Tooth Disease ENCell, a leading biopharmaceutical company specializing in cell and gene therapy, contract research, and manufacturing, has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation…

Read MoreENCell’s EN001 Gets FDA Orphan Drug Status for Charcot-Marie-Tooth Disease

MedLumics® Publishes FIM Results for AblaView® Ablation System in AF Patients

MedLumics® Publishes FIM Results for AblaView® Ablation System in AF Patients “We would like to extend our heartfelt thanks to the investigation site team, especially the investigators and proctors, for their invaluable contributions to this groundbreaking first-in-human trial. Their efforts…

Read MoreMedLumics® Publishes FIM Results for AblaView® Ablation System in AF Patients